Shikonin alleviates choroidal neovascularization by inhibiting proangiogenic factor production from infiltrating macrophages.

MLA

Wang, Ying, et al. “Shikonin Alleviates Choroidal Neovascularization by Inhibiting Proangiogenic Factor Production from Infiltrating Macrophages.” Experimental Eye Research, vol. 213, Dec. 2021, p. 108823. EBSCOhost, https://doi.org/10.1016/j.exer.2021.108823.

APA

Wang, Y., Xie, L., Zhu, M., Guo, Y., Tu, Y., Zhou, Y., Zeng, J., Zhu, L., Du, S., Wang, Z., Zhang, Y., Liu, X., & Song, E. (2021). Shikonin alleviates choroidal neovascularization by inhibiting proangiogenic factor production from infiltrating macrophages. Experimental Eye Research, 213, 108823. https://doi.org/10.1016/j.exer.2021.108823

Chicago

Wang, Ying, Laiqing Xie, Manhui Zhu, Yang Guo, Yuanyuan Tu, Yamei Zhou, Jia Zeng, et al. 2021. “Shikonin Alleviates Choroidal Neovascularization by Inhibiting Proangiogenic Factor Production from Infiltrating Macrophages.” Experimental Eye Research 213 (December): 108823. doi:10.1016/j.exer.2021.108823.